Myelodysplastic Syndromes NFZ — 37 facilities in 34 cities

Myelodysplastic syndromes (MDS) are bone marrow disorders with abnormal blood cell maturation leading to cytopenias. They manifest as anemia, susceptibility to infections, and bleeding. The NFZ covers diagnostics including bone marrow biopsy and cytogenetics, treatment with azacitidine and lenalidomide, transfusions, and bone marrow transplantation. Drug programs provide access to specialized therapies.